Study in mono and bilayers of the interaction of hepatitis G virus (GBV-C/HGV) synthetic antigen E2(99-118) with cell membrane phospholipids

Biophysical Chemistry

Volumn 109, Issue 3, 2004, Pages 375-385

  Dastis, Macarena ^a   Rojo, Nuria ^b   Alsina, M A ^a   Haro, Isabel ^b   Panda, Amiya Kumar ^c   Mestres, Concepció ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c BEHALA COLLEGE   (India)

Author keywords

Dipalmitoylphosphatidylcholine (DPPC); Dipalmitoylphosphatidylglycerol (DPPG); GBV C HGV; Hepatitis G; Monolayers

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; MEMBRANE PHOSPHOLIPID; VIRUS ANTIGEN;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; ELECTRICITY; EPIFLUORESCENCE MICROSCOPY; HEPATITIS G VIRUS; LANGMUIR BLODGETT FILM; PRIORITY JOURNAL; PROTEIN INTERACTION;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTIGENS, VIRAL; CELL MEMBRANE; DRUG INTERACTIONS; GB VIRUS C; LIPID BILAYERS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; PEPTIDES; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPIDS; THERMODYNAMICS;

GB VIRUS C/HEPATITIS G VIRUS;

EID: 1942540614     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2003.12.013     Document Type: Article

References (22)

1. B. Robertson, G. Myers, C. Howard, T. Brettin, J. Bukh, et al., Arch. Virol. 143 Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy, 143 (1998) 2493-2503.
2. Flint M., Thomas J.M., Maidens C.M., Shotton C., Levy S., Barclay W.S., et al. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 73:1999;6782.
3. Rojo N., Mestres C., Cruzado J.M., Ercilla G., Haro I. Benedetti E., Pedone C. Peptides 2002. Synthetic peptide based biosensors in immunodiagnosis of hepatitis G infection. 2002;958-959 Edizioni Ziino, Napoli, Italy.
4. Rojo N., Ercilla G., Haro I. GB virus C (GBV-C)/Hepatitis G virus (HGV): towards the design of synthetic peptides based biosensors for immunodiagnosis of GBV-C/HGV infection. Current Peptide Protein Sci. 4:2003;291-298.
5. Nag K., Munro J.G., Hearn S.A., Rasmusson J., Petersen N.O., Possmayer F. Correlated atomic force and transmission electron microscopy of nanotubular structures in pulmonary surfactant. J. Struct. Biol. 126:1999;1-15.
6. Ding J., Takamoto D.Y., von Nahmen A., Lipp M.M., Lee K.Y.C., Waring A.J., et al. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayers stability. Biophys. J. 8:2001;2262-2272.
7. Taneva S., Keough M.W. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids. Biophys. J. 66:1994;1137-1148.
8. Sospedra P., Espina M., Alsina M.A., Haro I., Mestres C. Miscibility of hepatitis A synthetic antigen peptides with lipid monolayers: effect of the amino acid sequence change. J. Phys. Chem. B. 107:2003;203-208.
9. Montero M.T., Hernandez-Borrell J., Keough K.M.W. Fluoroquinolone- biomembrane interactions: monolayer and calorimetric studies. Langmuir. 14:(9):1998;2451-2454.
10. Hasmonay H., Hoclpafel A., Hadj-Sahraoui, Jaffan M., Peretti P. Drugs in biomimetic models: a monolayers study of two antibiotics. Thin Solid Films. 210-211:1992;747-749.
11. Trommeshauser D., Galla H. Interaction of a basic amphipatic peptide from the carboxyterminal part of the HIV envelope protein gp41 with negatively charged lipid surfaces. Chem. Phys. Lipids. 94:1998;81-96.
12. Yu S., McCormack F., Voelker D., Possmayer F. Interaction of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol: roles of SP-A domains. J. Lipids Res. 40:1999;920-929.
13. Maget-Dana R., Lelièvre D. Comparative interaction of alfa-helical and beta-sheet amphipatic isopeptides with phospholipid monolayers. Biopolymers. 59:2001;1-10.
14. F.C. Goodrich, Proceedings of the 11th International Congress on Surface Activity, Bultorworths, London, 1957.
15. Pagano R.E., Gershfeld N.L. A millidyne film balance for measuring intermolecular energies in lipid films. J. Colloid Interface Sci. 41:(2):1972;311-317.
16. Nag K., Harbottle R., Panda A.K.J. Molecular architrecture of a self-assembled bio-interface: lung surfactant. Surf. Sci. Technol. 16:2000;156.
17. Wortham L.-A.D., Nag K., Davis P.J., Keough K.M.W. Cholesterol in condensed and fluid phosphatidylcholine monolayers studied by epifluorescence microscopy. Biophys. J. 72:1997;2569-2580.
18. Warriner H.E., Ding J., Waring A.J., Zasadzinski J.A. Concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants. Biophys. J. 82:February 2002;835-842.
19. Rojo N., Gomara M.J., Alsina M.A., Haro I. Lipophilic derivatization of synthetic peptides belonging to NS3 and E2 proteins of GB virus-C (hepatitis G virus) and its effect on the interaction with model lipid membranes. J. Peptide Res. 64:2003;318-330.
20. M.A. Alsina, M. Dastis, N. Rojo, I. Haro, C. Mestres, Miscibilité d'un antigène synthetique de l'Hepatite G avec dipalmitoylphosphatidylcholine et dipalmitoylphosphatidylglycerol. XXIX Journées d'Études des Equilibres entre Phases. Villeurbanne, Lyon (France), 2003, pp. 55-56.
21. Rojo N., Gómara M.J., Busquets M.A., Alsina M.A., Haro I. Interaction of E2 ad NS3 synthetic peptides of GB virus C/Hepatitis G virus with model lipid membranes. Talanta. 60:2003;395-404.
22. Fujii G. To fuse or not to fuse: the effects of electrostatic interactions, hydrophobic forces, and structural amphiphilicity on protein-mediated membrane destabilization. Adv. Drug Delivery Rev. 38:1999;257-277.